Literature DB >> 21997969

Activation of p53 signaling and inhibition of androgen receptor mediate tanshinone IIA induced G1 arrest in LNCaP prostate cancer cells.

Suk-Hyun Won1, Hyo-Jeong Lee, Soo-Jin Jeong, Junxuan Lü, Sung-Hoon Kim.   

Abstract

Our group previously reported that tanshinone IIA induced apoptosis via a mitochondria dependent pathway in LNCaP prostate cancer cells. In the present study, the roles of androgen receptor (AR) and p53 signaling pathways were investigated in tanshinone IIA-induced G1 arrest in LNCaP cells. Tanshinone IIA significantly inhibited the growth and proliferation of LNCaP cells by colony formation and BrdU incorporation assays, respectively. Tanshinone IIA induced cell cycle arrest at G1 phase and down-regulated cyclin D1, CDK2 and CDK4. Furthermore, tanshinone IIA activated the phosphorylation of p53 at Ser 15 residue and its downstream p21 and p27. Additionally, tanshinone IIA suppressed the expression of AR and prostate specific antigen (PSA). Conversely, silencing p53 using its specific siRNA reversed cyclin D1 expression inhibited by tanshinone IIA. However, knockdown of AR had no effect on the p53/p21/p27 signaling pathway activated by tanshinone IIA in LNCaP cells. In AR siRNA-transfected cells, tanshinone IIA did not cause cell cycle arrest and reduce cyclin D1, implying that AR is essential to induce G1 arrest by tanshinone IIA in LNCaP cells. Taken together, the findings suggest that tanshinone IIA induces G1 arrest via activation of p53 signaling and inhibition of AR in LNCaP cells.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21997969     DOI: 10.1002/ptr.3616

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  12 in total

1.  Zinc finger protein 746 promotes colorectal cancer progression via c-Myc stability mediated by glycogen synthase kinase 3β and F-box and WD repeat domain-containing 7.

Authors:  Ji Hoon Jung; Deok-Beom Jung; Hyunseok Kim; Hyemin Lee; Shi-Eun Kang; Sanjay K Srivastava; Miyong Yun; Sung-Hoon Kim
Journal:  Oncogene       Date:  2018-04-09       Impact factor: 9.867

2.  Tanshinone IIA enhances chemosensitivity of colon cancer cells by suppressing nuclear factor-κB.

Authors:  Yangqiu Bai; Lida Zhang; Xinhui Fang; Yuxiu Yang
Journal:  Exp Ther Med       Date:  2016-01-12       Impact factor: 2.447

3.  High-throughput cell-based compound screen identifies pinosylvin methyl ether and tanshinone IIA as inhibitors of castration-resistant prostate cancer.

Authors:  Kirsi Ketola; Miro Viitala; Pekka Kohonen; Vidal Fey; Zoran Culig; Olli Kallioniemi; Kristiina Iljin
Journal:  J Mol Biochem       Date:  2016-03-30

4.  Tanshinone IIA inhibits hypoxia-induced pulmonary artery smooth muscle cell proliferation via Akt/Skp2/p27-associated pathway.

Authors:  Ying Luo; Dun-Quan Xu; Hai-Ying Dong; Bo Zhang; Yi Liu; Wen Niu; Ming-Qing Dong; Zhi-Chao Li
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

5.  Integrating transcriptomics and proteomics to show that tanshinone IIA suppresses cell growth by blocking glucose metabolism in gastric cancer cells.

Authors:  Li-Ling Lin; Chieh-Ren Hsia; Chia-Lang Hsu; Hsuan-Cheng Huang; Hsueh-Fen Juan
Journal:  BMC Genomics       Date:  2015-02-05       Impact factor: 3.969

6.  A promising "TRAIL" of tanshinones for cancer therapy.

Authors:  Tsing-Fen Ho; Chia-Che Chang
Journal:  Biomedicine (Taipei)       Date:  2015-11-28

7.  Anti-Cancer Effect of Lambertianic Acid by Inhibiting the AR in LNCaP Cells.

Authors:  Myoung-Sun Lee; Seon-Ok Lee; Sung-Hoon Kim; Eun-Ok Lee; Hyo-Jeong Lee
Journal:  Int J Mol Sci       Date:  2016-07-07       Impact factor: 5.923

Review 8.  Tanshinones: sources, pharmacokinetics and anti-cancer activities.

Authors:  Yong Zhang; Peixin Jiang; Min Ye; Sung-Hoon Kim; Cheng Jiang; Junxuan Lü
Journal:  Int J Mol Sci       Date:  2012-10-22       Impact factor: 5.923

9.  Apoptosis Induced by Tanshinone IIA and Cryptotanshinone Is Mediated by Distinct JAK/STAT3/5 and SHP1/2 Signaling in Chronic Myeloid Leukemia K562 Cells.

Authors:  Ji Hoon Jung; Tae-Rin Kwon; Soo-Jin Jeong; Eun-Ok Kim; Eun Jung Sohn; Miyong Yun; Sung-Hoon Kim
Journal:  Evid Based Complement Alternat Med       Date:  2013-06-26       Impact factor: 2.629

10.  A Three-Gene Classifier Associated With MicroRNA-Mediated Regulation Predicts Prostate Cancer Recurrence After Radical Prostatectomy.

Authors:  Bo Cheng; Qidan He; Yong Cheng; Haifan Yang; Lijun Pei; Qingfu Deng; Hao Long; Likun Zhu; Rui Jiang
Journal:  Front Genet       Date:  2020-02-04       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.